These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 18200644)
1. An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Saini V; Martyshkin DV; Mirov SB; Perez A; Perkins G; Ellisman MH; Towner VD; Wu H; Pereboeva L; Borovjagin A; Curiel DT; Everts M Small; 2008 Feb; 4(2):262-9. PubMed ID: 18200644 [TBL] [Abstract][Full Text] [Related]
2. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Chorny M; Fishbein I; Alferiev I; Levy RJ Mol Pharm; 2009; 6(5):1380-7. PubMed ID: 19496618 [TBL] [Abstract][Full Text] [Related]
3. Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Everts M; Saini V; Leddon JL; Kok RJ; Stoff-Khalili M; Preuss MA; Millican CL; Perkins G; Brown JM; Bagaria H; Nikles DE; Johnson DT; Zharov VP; Curiel DT Nano Lett; 2006 Apr; 6(4):587-91. PubMed ID: 16608249 [TBL] [Abstract][Full Text] [Related]
4. Zwitterion-functionalized dendrimer-entrapped gold nanoparticles for serum-enhanced gene delivery to inhibit cancer cell metastasis. Xiong Z; Alves CS; Wang J; Li A; Liu J; Shen M; Rodrigues J; Tomás H; Shi X Acta Biomater; 2019 Nov; 99():320-329. PubMed ID: 31513912 [TBL] [Abstract][Full Text] [Related]
5. A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Douglas JT; Miller CR; Kim M; Dmitriev I; Mikheeva G; Krasnykh V; Curiel DT Nat Biotechnol; 1999 May; 17(5):470-5. PubMed ID: 10331807 [TBL] [Abstract][Full Text] [Related]
6. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models. Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331 [TBL] [Abstract][Full Text] [Related]
8. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Campos SK; Parrott MB; Barry MA Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061 [TBL] [Abstract][Full Text] [Related]
9. Study on nanocomposite construction based on the multi-functional biotemplate self-assembled by the recombinant TMGMV coat protein for potential biomedical applications. Song L; Wang S; Wang H; Zhang H; Cong H; Jiang X; Tien P J Mater Sci Mater Med; 2015 Feb; 26(2):97. PubMed ID: 25652772 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticle superstructures made by polymerase chain reaction: collective interactions of nanoparticles and a new principle for chiral materials. Chen W; Bian A; Agarwal A; Liu L; Shen H; Wang L; Xu C; Kotov NA Nano Lett; 2009 May; 9(5):2153-9. PubMed ID: 19320495 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery. Li J; Lad S; Yang G; Luo Y; Iacobelli-Martinez M; Primus FJ; Reisfeld RA; Li E J Virol; 2006 Dec; 80(24):12324-31. PubMed ID: 17020947 [TBL] [Abstract][Full Text] [Related]
12. Encapsulating gold nanoparticles or nanorods in graphene oxide shells as a novel gene vector. Xu C; Yang D; Mei L; Lu B; Chen L; Li Q; Zhu H; Wang T ACS Appl Mater Interfaces; 2013 Apr; 5(7):2715-24. PubMed ID: 23477862 [TBL] [Abstract][Full Text] [Related]
13. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting. Jönsson F; Hagedorn C; Kreppel F J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881 [TBL] [Abstract][Full Text] [Related]
14. Limitations of Adenoviral Vector-Mediated Delivery of Gold Nanoparticles to Tumors for Hyperthermia Induction. Saini V; Martyshki DV; Towner VD; Mirov SB; Everts M Open Nanomed J; 2009; 2():. PubMed ID: 24403982 [TBL] [Abstract][Full Text] [Related]
15. Theranostic Nanoparticles for RNA-Based Cancer Treatment. Revia RA; Stephen ZR; Zhang M Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134 [TBL] [Abstract][Full Text] [Related]
16. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system. Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768 [TBL] [Abstract][Full Text] [Related]
17. A one-pot strategy for biomimetic synthesis and self-assembly of gold nanoparticles. Wang Y; Chen LQ; Li YF; Zhao XJ; Peng L; Huang CZ Nanotechnology; 2010 Jul; 21(30):305601. PubMed ID: 20603532 [TBL] [Abstract][Full Text] [Related]
18. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors. Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972 [TBL] [Abstract][Full Text] [Related]
19. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. Korokhov N; Mikheeva G; Krendelshchikov A; Belousova N; Simonenko V; Krendelshchikova V; Pereboev A; Kotov A; Kotova O; Triozzi PL; Aldrich WA; Douglas JT; Lo KM; Banerjee PT; Gillies SD; Curiel DT; Krasnykh V J Virol; 2003 Dec; 77(24):12931-40. PubMed ID: 14645549 [TBL] [Abstract][Full Text] [Related]